相关实验视频

Updated: May 6, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

用于糖尿病患者皮肤冠状动脉干预的无聚合物支架:系统性审查和元分析

Filippo Luca Gurgoglione¹, Davide Donelli¹, Michele Antonelli²

¹Division of Cardiology, University of Parma, Parma University Hospital, Parma, Italy.

Future cardiology

|July 9, 2024

概括

无聚合物释放药物支架 (PF-DES) 在接受冠状动脉干预的糖尿病患者中显示出较低目标病变衰竭的趋势,并显著降低了心脏死亡率. 进一步的分析表明,PF-DES可能是这个人群的有价值策略.

科学领域:

心脏病学心脏病学
干预心脏病学干预心脏病学
生物材料在医学中的应用

背景情况:

冠状动脉疾病 (CAD) 对糖尿病患者构成重大风险.
穿皮冠状动脉干预 (PCI) 是对CAD的常见治疗方法.
药物排泄支架 (DES) 旨在减少复原,但聚合物涂层可能会引起炎症.

研究的目的:

评估无聚合物药物释放支架 (PF-DES) 与其他支架类型相比,在接受PCI的糖尿病患者中具有CAD的疗效.
评估目标病变衰竭 (TLF) 的初级终点和包括心脏死亡率在内的二级终点.

主要方法:

进行了随机对照试验 (RCT) 的系统审查和元分析.
这项分析包括了8项涉及4854名受试者的RCT.
测量的主要结果是目标病变失败.

主要成果:

在PF-DES组中,出现了较低目标病变失败的趋势 (IRR = 0.91,p = 0.11).
与对照组相比,PF-DES组观察到心脏病死亡率的统计显著降低 (IRR = 0.82,p = 0.04).
除了裸金属支架患者,统计学意义下降,只有心脏病死亡率的趋势有利于PF-DES.

结论:

无聚合物释放药物支架 (PF-DES) 可能是接受PCI的冠状动脉疾病糖尿病患者的有价值的治疗策略.
在这种高风险人群中,PF-DES显示出降低心脏病死亡率的希望.
可能需要进一步的研究来证实PF-DES在特定患者亚组中的益处.

关键词:

动脉样硬化动脉样硬化在糖尿病中,糖尿病是血糖类的.进行元分析分析.通过皮肤进行冠状动脉干预.无聚合物药物排泄支架无聚合物预后预后预后

更多相关视频

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Published on: October 26, 2016

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease

Published on: February 18, 2020

相关概念视频

Coronary Artery Disease V: Interprofessional Care

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...

Diabetic Retinopathy

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...